These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1699285

  • 1. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM, Redman JR, Keating MJ.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [Abstract] [Full Text] [Related]

  • 2. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML, Zaritskiĭ AIu, Medvedeva NV, Abdulkadyrov KM, Samuskevich IG, Beresneva IA.
    Vopr Onkol; 1998 Oct; 44(6):696-700. PubMed ID: 10087967
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG, Leyland-Jones B, Cheson BD.
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [Abstract] [Full Text] [Related]

  • 5. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
    Keating MJ.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL.
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase I clinical trials with fludarabine phosphate.
    Von Hoff DD.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM.
    J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary toxicity associated with fludarabine monophosphate.
    Hurst PG, Habib MP, Garewal H, Bluestein M, Paquin M, Greenberg BR.
    Invest New Drugs; 1987 Apr 01; 5(2):207-10. PubMed ID: 2443463
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.